Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yadi Zhou

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Bioengineered|October 13, 2021
The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axisYadi Zhou, Zhenghao Zhang, Mingyi Wo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentFeixiong Cheng, Yadi Zhou, Yuan Hou, et al.
The Lancet. Digital Health|September 28, 2020
Artificial intelligence in COVID-19 drug repurposingYadi Zhou, Fei Wang, Jian Tang, et al.
3 Biotech|May 5, 2025
Comparative studies on enzymatic changes and structure of lipases under ultrasoundXueyu Qiu, Yadi Zhou, Mingchun Zhou, et al.
Plos One|July 21, 2012
Prediction of chemical-protein interactions network with weighted network-based inference methodFeixiong Cheng, Yadi Zhou, Weihua Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentZhendong Sha, Yadi Zhou, Yuan Hou, et al.
Frontiers in Plant Science|June 30, 2020
Tissue Composition of <i>Agave americana</i> L. Yields Greater Carbohydrates From Enzymatic Hydrolysis Than Advanced Bioenergy CropsAlexander M Jones, Yadi Zhou, Michael A Held, et al.
Frontiers in Neuroscience|March 18, 2021
The Epidemiological and Mechanistic Understanding of the Neurological Manifestations of COVID-19: A Comprehensive Meta-Analysis and a Network Medicine ObservationJiayu Shen, Yuan Hou, Yadi Zhou, et al.
Alzheimer'S & Dementia (New York, N. Y.)|May 30, 2023
Alzheimer's disease drug development pipeline: 2023Jeffrey Cummings, Yadi Zhou, Garam Lee, et al.
Translational Andrology and Urology|May 16, 2025
Piperlongumine inhibits renal cell carcinoma progression by modulating the DDX11-miR-15b-3p-DLD axisZhenghao Zhang, Wenfang Xu, Kewen Ye, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Bioengineered|October 13, 2021
The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axisYadi Zhou, Zhenghao Zhang, Mingyi Wo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentFeixiong Cheng, Yadi Zhou, Yuan Hou, et al.
The Lancet. Digital Health|September 28, 2020
Artificial intelligence in COVID-19 drug repurposingYadi Zhou, Fei Wang, Jian Tang, et al.
3 Biotech|May 5, 2025
Comparative studies on enzymatic changes and structure of lipases under ultrasoundXueyu Qiu, Yadi Zhou, Mingchun Zhou, et al.
Plos One|July 21, 2012
Prediction of chemical-protein interactions network with weighted network-based inference methodFeixiong Cheng, Yadi Zhou, Weihua Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentZhendong Sha, Yadi Zhou, Yuan Hou, et al.
Frontiers in Plant Science|June 30, 2020
Tissue Composition of <i>Agave americana</i> L. Yields Greater Carbohydrates From Enzymatic Hydrolysis Than Advanced Bioenergy CropsAlexander M Jones, Yadi Zhou, Michael A Held, et al.
Frontiers in Neuroscience|March 18, 2021
The Epidemiological and Mechanistic Understanding of the Neurological Manifestations of COVID-19: A Comprehensive Meta-Analysis and a Network Medicine ObservationJiayu Shen, Yuan Hou, Yadi Zhou, et al.
Alzheimer'S & Dementia (New York, N. Y.)|May 30, 2023
Alzheimer's disease drug development pipeline: 2023Jeffrey Cummings, Yadi Zhou, Garam Lee, et al.
Translational Andrology and Urology|May 16, 2025
Piperlongumine inhibits renal cell carcinoma progression by modulating the DDX11-miR-15b-3p-DLD axisZhenghao Zhang, Wenfang Xu, Kewen Ye, et al.
Pageof 9